1
|
Ota H, Mukaino M, Inoue Y, Matsuura S, Yagi S, Kanada Y, Saitoh E, Otaka Y. Movement Component Analysis of Reaching Strategies in Individuals With Stroke: Preliminary Study. JMIR Rehabil Assist Technol 2023; 10:e50571. [PMID: 38051570 PMCID: PMC10731574 DOI: 10.2196/50571] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2023] [Revised: 08/29/2023] [Accepted: 09/21/2023] [Indexed: 12/07/2023] Open
Abstract
BACKGROUND Upper limb motor paresis is a major symptom of stroke, which limits activities of daily living and compromises the quality of life. Kinematic analysis offers an in-depth and objective means to evaluate poststroke upper limb paresis, with anticipation for its effective application in clinical settings. OBJECTIVE This study aims to compare the movement strategies of patients with hemiparesis due to stroke and healthy individuals in forward reach and hand-to-mouth reach, using a simple methodology designed to quantify the contribution of various movement components to the reaching action. METHODS A 3D motion analysis was conducted, using a simplified marker set (placed at the mandible, the seventh cervical vertebra, acromion, lateral epicondyle of the humerus, metacarpophalangeal [MP] joint of the index finger, and greater trochanter of the femur). For the forward reach task, we measured the distance the index finger's MP joint traveled from its starting position to the forward target location on the anterior-posterior axis. For the hand-to-mouth reach task, the shortening of the vertical distance between the index finger MP joint and the position of the chin at the start of the measurement was measured. For both measurements, the contributions of relevant upper limb and trunk movements were calculated. RESULTS A total of 20 healthy individuals and 10 patients with stroke participated in this study. In the forward reach task, the contribution of shoulder or elbow flexion was significantly smaller in participants with stroke than in healthy participants (mean 52.5%, SD 24.5% vs mean 85.2%, SD 4.5%; P<.001), whereas the contribution of trunk flexion was significantly larger in stroke participants than in healthy participants (mean 34.0%, SD 28.5% vs mean 3.0%, SD 2.8%; P<.001). In the hand-to-mouth reach task, the contribution of shoulder or elbow flexion was significantly smaller in participants with stroke than in healthy participants (mean 71.8%, SD 23.7% vs mean 90.7%, SD 11.8%; P=.009), whereas shoulder girdle elevation and shoulder abduction were significantly larger in participants with stroke than in healthy participants (mean 10.5%, SD 5.7% vs mean 6.5%, SD 3.0%; P=.02 and mean 16.5%, SD 18.7% vs mean 3.0%, SD 10.4%; P=.02, respectively). CONCLUSIONS Compared with healthy participants, participants with stroke achieved a significantly greater distance via trunk flexion in the forward reach task and shoulder abduction and shoulder girdle elevation in the hand-to-mouth reach task, both of these differences are regarded as compensatory movements. Understanding the characteristics of individual motor strategies, such as dependence on compensatory movements, may contribute to tailored goal setting in stroke rehabilitation.
Collapse
Affiliation(s)
- Hirofumi Ota
- Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan
| | - Masahiko Mukaino
- Department of Rehabilitation Medicine, Hokkaido University Hospital, Sapporo, Japan
- Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Japan
| | - Yukari Inoue
- Department of Rehabilitation, Fujita Health University Hospital, Toyoake, Japan
| | - Shoh Matsuura
- Department of Rehabilitation, Fujita Health University Hospital, Toyoake, Japan
| | - Senju Yagi
- Department of Rehabilitation, Fujita Health University Hospital, Toyoake, Japan
| | - Yoshikiyo Kanada
- Faculty of Rehabilitation, School of Health Sciences, Fujita Health University, Toyoake, Japan
| | - Eiichi Saitoh
- Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Japan
| | - Yohei Otaka
- Department of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Toyoake, Japan
| |
Collapse
|
2
|
Yamaguchi K, Wakatsuki T, Okushi Y, Suto K, Matsumoto K, Takahashi T, Kadota M, Kawabata Y, Matsuura T, Ise T, Kusunose K, Yagi S, Yamada H, Soeki T, Sata M. Early and chronic phased local coagulative responses following bioresorbable-polymer drug-eluting stent implantation. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1245] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Neointimal maturation after bioresorbable-polymer (BP) drug-eluting stent (DES) implantation will not be complete in the absorption phase of the polymer. We have previously reported local persistent hypercoagulation after sirolimus-eluting stent (SES) implantation by measuring local plasma prothrombin fragment 1+2 (F1+2) levels. The aim of this study is to examine time-dependent local coagulative response after BP-DES implantation.
Methods
Sixty-four patients who were treated about ten months earlier with coronary angioplasty, with no evidence of restenosis, were studied [durable-polymer (DP)-DES {SES; Cypher®: 26pts and everolimus-eluting stent (EES); Xience®: 16pts} and BP-DES (BP-EES; Synergy®: 10pts and BP-SES; Ultimaster®: 12pts)]. We measured plasma levels of F1+2 sampled in coronary sinus (CS) and sinus of Valsalva (V) at the early (2±1 months) and chronic (10±2 months) phases. The transcardiac gradient (Δ) was defined as CS level minus V level.
Results
No significant differences were observed in the percent diameter stenosis between the DP- and BP- DES groups (11.5±15.5 vs 14.1±11.9%). The ΔF1+2 was significantly lower in the BP-DES group than in the DP-DES group at the chronic phase (7.5±16.1 vs 16.4±17.1pmol/l, p<0.05). In the BP-DES group, the ΔF1+2 did not differ significantly between the early and chronic phases (7.0±14.1 vs 7.5±16.1pmol/l, NS).
Conclusion
Lower local coagulative response was observed at the chronic phase after BP-DES implantation compared to DP-DES implantation, and local hypercoagulation after BP-DES implantation was not observed at the early phase compared to the chronic phase. These findings might lead to the possibility of shorter dual antiplatelet therapy after BP-DES implantation.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- K Yamaguchi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Wakatsuki
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - Y Okushi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - K Suto
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - K Matsumoto
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Takahashi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - M Kadota
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - Y Kawabata
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Matsuura
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Ise
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - K Kusunose
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - S Yagi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - H Yamada
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Soeki
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - M Sata
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| |
Collapse
|
3
|
Kumagai K, Yagi S, Yamaguchi T, Nagashima K, Nomura T, Watanabe M, Makuuchi R, Kawakami K, Otsuka S, Matsushima T, Kadowaki S, Haruta S, Cho H, Yamada T, Kakihara N, Imai Y, Fukunaga H, Saeki Y, Kanaji S, Boku N, Goto M. P-83 The efficacy of chemotherapy for gastric cancer with early recurrence during or after adjuvant S-1. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
4
|
Kamo N, Kaido T, Hamaguchi Y, Shirai H, Yagi S, Uemoto S. Pretransplant abnormal body composition is closely related to bacteremia after living donor liver transplantation. Clin Nutr ESPEN 2020. [DOI: 10.1016/j.clnesp.2020.09.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
5
|
Soeki T, Matsumoto K, Fukuda D, Uematsu E, Matsuura T, Tobiume T, Kusunose K, Ise T, Yamaguchi K, Yagi S, Yamada H, Wakatsuki T, Sata M. Toll-like receptor 9 is a novel therapeutic target to prevent atrial fibrillation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Atrial fibrillation (AF) is the most common type of arrhythmia seen in clinical practice. Recent studies suggest that inflammation contributes to the pathogenesis of AF. On the other hand, several evidence suggests that toll-like receptor (TLR) 9 recognizes bacterial DNA, activating innate immunity, whereas it also provokes inflammation in response to fragmented DNA released from mammalian cells. Recently, we have reported that TLR 9 plays a pivotal role in the development of vascular inflammation and atherogenesis through proinflammatory activation of macrophages.
Purpose
This study aimed to assess whether TLR9 contributes to the AF arrhythmogenesis.
Methods
TLR9 deficient (TLR9−/−) and wild-type mice were infused with angiotensin II (Ang II) or vehicle via an osmotic minipump for 4 weeks. Blood pressure and body weight were measured serially. Then, we examined AF inducibility by intracardiac electrophysiological study and the inflammation-induced atrial remodeling by biochemical analysis after 4 weeks of Ang II infusion.
Results
There was no significant difference in blood pressure and pulse rate between TLR9−/− and wild-type mice both before and after Ang II infusion. Ang II-treated TLR9−/− mice showed lower incidence of AF compared with wild-type mice treated with Ang II. Genetic deletion of TLR9 significantly reduced the interstitial fibrosis in atrium of Ang II-treated mice. TLR9−/− mice also showed less mRNA expressions of inflammatory and fibrosis-related biomarkers (TNF-α, interleukin-6, TGF-β, collagen-1, collagen-3) in atrium compared with wild-type mice.
Conclusions
TLR9 might contribute to the AF arrhythmogenesis associated with atrial inflammation. TLR9 might serve as a potential therapeutic target for AF.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- T Soeki
- Tokushima University, Tokushima, Japan
| | | | - D Fukuda
- Tokushima University, Tokushima, Japan
| | - E Uematsu
- Tokushima University, Tokushima, Japan
| | | | - T Tobiume
- Tokushima University, Tokushima, Japan
| | | | - T Ise
- Tokushima University, Tokushima, Japan
| | | | - S Yagi
- Tokushima University, Tokushima, Japan
| | - H Yamada
- Tokushima University, Tokushima, Japan
| | | | - M Sata
- Tokushima University, Tokushima, Japan
| |
Collapse
|
6
|
Tanaka M, Takechi M, Homma A, Fukuda M, Nishimura D, Suzuki T, Tanaka Y, Moriguchi T, Ahn DS, Aimaganbetov A, Amano M, Arakawa H, Bagchi S, Behr KH, Burtebayev N, Chikaato K, Du H, Ebata S, Fujii T, Fukuda N, Geissel H, Hori T, Horiuchi W, Hoshino S, Igosawa R, Ikeda A, Inabe N, Inomata K, Itahashi K, Izumikawa T, Kamioka D, Kanda N, Kato I, Kenzhina I, Korkulu Z, Kuk Y, Kusaka K, Matsuta K, Mihara M, Miyata E, Nagae D, Nakamura S, Nassurlla M, Nishimuro K, Nishizuka K, Ohnishi K, Ohtake M, Ohtsubo T, Omika S, Ong HJ, Ozawa A, Prochazka A, Sakurai H, Scheidenberger C, Shimizu Y, Sugihara T, Sumikama T, Suzuki H, Suzuki S, Takeda H, Tanaka YK, Tanihata I, Wada T, Wakayama K, Yagi S, Yamaguchi T, Yanagihara R, Yanagisawa Y, Yoshida K, Zholdybayev TK. Swelling of Doubly Magic ^{48}Ca Core in Ca Isotopes beyond N=28. Phys Rev Lett 2020; 124:102501. [PMID: 32216444 DOI: 10.1103/physrevlett.124.102501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2019] [Revised: 12/20/2019] [Accepted: 01/30/2020] [Indexed: 06/10/2023]
Abstract
Interaction cross sections for ^{42-51}Ca on a carbon target at 280 MeV/nucleon have been measured for the first time. The neutron number dependence of derived root-mean-square matter radii shows a significant increase beyond the neutron magic number N=28. Furthermore, this enhancement of matter radii is much larger than that of the previously measured charge radii, indicating a novel growth in neutron skin thickness. A simple examination based on the Fermi-type distribution, and mean field calculations point out that this anomalous enhancement of the nuclear size beyond N=28 results from an enlargement of the core by a sudden increase in the surface diffuseness of the neutron density distribution, which implies the swelling of the bare ^{48}Ca core in Ca isotopes beyond N=28.
Collapse
Affiliation(s)
- M Tanaka
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
- Research Center for Superheavy Elements, Kyushu University, Fukuoka 819-0395, Japan
| | - M Takechi
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - A Homma
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - M Fukuda
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - D Nishimura
- Department of Physics, Tokyo City University, Setagaya, Tokyo 158-8557, Japan
| | - T Suzuki
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - Y Tanaka
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - T Moriguchi
- Institute of Physics, University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - D S Ahn
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - A Aimaganbetov
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
- L.N. Gumilyov Eurasian National University, 010008 Astana, Kazakhstan
| | - M Amano
- Institute of Physics, University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - H Arakawa
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - S Bagchi
- Astronomy and Physics Department, Saint Mary's University, Halifax, Nova Scotia B3H 3C3, Canada
- Justus Liebig University, 35392 Giessen, Germany
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - K-H Behr
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - N Burtebayev
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
| | - K Chikaato
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - H Du
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - S Ebata
- Department of Physics, Saitama University, Saitama 338-8570, Japan
- School of Environment and Society, Tokyo Institute of Technology, Meguro, Tokyo 152-8551, Japan
| | - T Fujii
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - N Fukuda
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - H Geissel
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - T Hori
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - W Horiuchi
- Department of Physics, Hokkaido University, Sapporo 060-0810, Japan
| | - S Hoshino
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - R Igosawa
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - A Ikeda
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - N Inabe
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - K Inomata
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - K Itahashi
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - T Izumikawa
- Institute for Research Promotion, Niigata University, Niigata 950-8510, Japan
| | - D Kamioka
- Institute of Physics, University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - N Kanda
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - I Kato
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - I Kenzhina
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
- Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan
| | - Z Korkulu
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - Y Kuk
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
- L.N. Gumilyov Eurasian National University, 010008 Astana, Kazakhstan
| | - K Kusaka
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - K Matsuta
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - M Mihara
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - E Miyata
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - D Nagae
- Research Center for Superheavy Elements, Kyushu University, Fukuoka 819-0395, Japan
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - S Nakamura
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - M Nassurlla
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
- Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan
| | - K Nishimuro
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - K Nishizuka
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - K Ohnishi
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - M Ohtake
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - T Ohtsubo
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - S Omika
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - H J Ong
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - A Ozawa
- Institute of Physics, University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - A Prochazka
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - H Sakurai
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
- Department of Physics, University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - C Scheidenberger
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - Y Shimizu
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - T Sugihara
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - T Sumikama
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - H Suzuki
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - S Suzuki
- Institute of Physics, University of Tsukuba, Tsukuba, Ibaraki 305-8571, Japan
| | - H Takeda
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - Y K Tanaka
- GSI Helmholtzzentrum für Schwerionenforschung, 64291 Darmstadt, Germany
| | - I Tanihata
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
- School of Physics and Nuclear Energy Engineering, Beihang University, 100191 Beijing, China
| | - T Wada
- Department of Physics, Niigata University, Ikarashi, Niigata 951-2181, Japan
| | - K Wakayama
- Department of Physics, Saitama University, Saitama 338-8570, Japan
| | - S Yagi
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - T Yamaguchi
- Department of Physics, Saitama University, Saitama 338-8570, Japan
- Tomonaga Center for the History of the Universe, University of Tsukuba, Ibaraki 305-8571, Japan
| | - R Yanagihara
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - Y Yanagisawa
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - K Yoshida
- RIKEN Nishina Center, Wako, Saitama 351-0198, Japan
| | - T K Zholdybayev
- Institute of Nuclear Physics, 050032 Almaty, Kazakhstan
- Al-Farabi Kazakh National University, 050040 Almaty, Kazakhstan
| |
Collapse
|
7
|
Yamaguchi K, Wakatsuki T, Ueno R, Kawabata Y, Matsuura T, Ise T, Kusunose K, Tobiume T, Yagi S, Yamada H, Soeki T, Sata M. P2813The improvement of chronic local coagulative response according to the progress of drug eluting stent. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
We have previously reported local persistent hypercoagulation after sirolimus-eluting stent (SES) implantation by measuring local plasma prothrombin fragment 1+2 (F1+2) levels. The aim of this study is to examine chronic local coagulative response after each generation- drug eluting stent (DES) implantation.
Methods
Ninety-five patients who were treated about eight months earlier with coronary angioplasty, with no evidence of restenosis, were studied [1stgeneration durable polymer (DP)-DES {SES; Cypher®: 26pts, paclitaxel-eluting stent (PES); Taxus®:16pts}, 2ndgeneration DP-DES {everolimus-eluting stent (EES); Xience®:15pts, zotarolimus-eluting stent (ZES); Endeavor®:15pts}, and 3rdgeneration biodegradable polymer (BP)-DES {BP-biolimus-eluting stent (BES); Nobori®: 11pts and BP-SES; Ultimaster®: 12pts}]. We measured plasma levels of F1+2 sampled in coronary sinus (CS) and sinus of Valsalva (V). The transcardiac gradient (Δ) was defined as CS level minus V level.
Results
No significant differences were observed in the percent diameter stenosis among 1st, 2nd, and 3rd DES groups (12.5±15.5 vs 16.1±12.9 vs 13.1±11.9%). The ΔF1+2 was significantly lower in the 2nd and 3rd DES groups than in the 1st DES group (9.0±15.4 and 10.0±17.4 vs 27.3±23.8pmol/l, p<0.05, respectively). The ΔF1+2 was significantly lower in the BP-DES groups (BP-BES and BP-SES) than in the DP-DES groups (DP-SES, DP-PES, DP-ZES, and DP-EES) (10.0±17.4 vs 18.1±19.5pmol/l, p<0.05). The ΔF1+2 was significantly lower in the thin strut-DES groups (BP-SES, DP-ZES, and DP-EES) than in the thick strut-DES groups (DP-SES, DP-PES, and BP-BES) (8.4±15.4 vs 21.7±18.5pmol/l, p<0.05). In the BP-DES groups, the ΔF1+2 was lower in the BP-SES group than in the BP-BES group (8.0±16.1 vs 12.7±18.1pmol/l, p=0.08).
Conclusions
The improvement of chronic local coagulative response was observed according to the progress of DES. These findings might be associated with lower strut thickness and faster polymer resorption in the newer-generation DES.
Collapse
Affiliation(s)
- K Yamaguchi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Wakatsuki
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - R Ueno
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - Y Kawabata
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Matsuura
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Ise
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - K Kusunose
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Tobiume
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - S Yagi
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - H Yamada
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - T Soeki
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| | - M Sata
- Department of Cardiovascular Medicine, Tokushima University Hospital, Tokushima, Japan
| |
Collapse
|
8
|
Maimaituxun G, Kusunose K, Fukuda D, Yagi S, Torii Y, Hirata Y, Nishio S, Yamada NAO, Yamada H, Soeki T, Wakatsuki T, Sata M, Shimabukuro M. P3437Impact of epicardial adipose tissue on global longitudinal strain: a study in patients with normal left ventricular ejection fraction. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Epicardial adipose tissue (EAT) locates anatomically and functionally contiguous to the myocardium and coronary arteries. It has been suggested that EAT accumulation is associated with cardiac remodeling and impaired cardiac performance. However, its role in left ventricular (LV) wall strain remains unclear.
Purpose
In this study, we aimed to clarify: whether EAT accumulation is related to global longitudinal (GLS), circumferential (CS) and radial strain (RS); and if so, in which extent or by which amount of EAT are required to deteriorate these strain.
Methods
Total 180 patients who had no obstructive coronary artery disease (CAD) on multi-detector computed tomography (MDCT) coronary angiography and normal left ventricular ejection fraction (LVEF) on conventional echocardiography were recruited. Cardiac CT was used to quantify EAT volume (EATV) and echocardiographic speckle tracking was used to measure the GLS, CS and RS. EATV index (EATV/Body surface area) was determined as: EAT volume, the sum of the EAT area from the base to the apex of the heart (cm3)/body surface area (m2). Adipose tissue was determined as the density range between −190 and −30 Hounsfield unit. According to the median value (68 cm3/m2), patients were divided into lower and higher EATV index two groups.
Results
In higher EATV index group (95±19 cm3/m2), mean age, body mass index (BMI), prevalence of hyperlipidemia and prevalence of CAD were larger than in lower EATV index group (48±14 cm3/m2). Male gender, hypertension, diabetes, smoking and LV mass index were comparable between two groups. Patients in higher EATV index had lower GLS than those in lower EATV index (−19.4±1.2% vs. −18.8±1.3%, p=0.002). However, there were no significant difference between two groups regarding to the CS and RS. Linear regression analysis showed that there was strong correlation between EATV index and GLS (R=0.216, p=0.004); whereas, both RS and CS were strongly associated with the interventricular septum thickness (RS: R=0.248, p=0.003; CS: R= −0.192, p=0.023) and relative wall thickness (RS: R=0.178, p=0.036; CS: R= −0.184, p=0.030) but not with EATV; on multiple regression analysis, EATV was a predictor of GLS independent of age, male gender, BMI, diabetes, hyperlipidemia, hypertension and CAD (Adjusted R2=0.238, p<0.001).
Conclusion
EATV is independently associated with GLS despite the preserved LVEF and lacking of obstructive CAD, and may play a significant role in estimating impaired longitudinal LV performance.
Collapse
Affiliation(s)
- G Maimaituxun
- Fukushima Medical University, Department of Diabetes, Endocrinology and Metabolism, School of Medicine, Fukushima, Japan
| | - K.E.N.Y.A Kusunose
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - D.A.I.J.U Fukuda
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - S Yagi
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - Y Torii
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - Y.U.K.I.N.A Hirata
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - S Nishio
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - N A O Yamada
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - H Yamada
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Soeki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Wakatsuki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Sata
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Shimabukuro
- Fukushima Medical University, Department of Diabetes, Endocrinology and Metabolism, School of Medicine, Fukushima, Japan
| |
Collapse
|
9
|
Soeki T, Matsumoto K, Fukuda D, Uematsu E, Matsuura T, Tobiume T, Kusunose K, Ise T, Yamaguchi K, Yagi S, Yamada H, Wakatsuki T, Sata M. P2867Vildagliptin reduces inducibility of atrial fibrillation in hypertensive rats complicated with diabetes mellitus. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.1176] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, increasing the incidence of ischemic stroke. Diabetes mellitus (DM) is a predictor of stroke and thromboembolism, and it was reported to be an independent risk factor for AF. A recent study has shown that, in obese mice with diabetes, dipeptidyl peptidase-4 (DPP-4) inhibitor prevents myocardial fibrosis, active oxygen stress, weight loss and improves myocardial hypertrophy. However, the effects of DPP-4 inhibitors on atrial remodeling associated with diabetes and atrial fibrillation have not yet been clarified.
Purpose
This study was performed to assess whether a DPP-4 inhibitor (vildagliptin) ameliorates atrial remodeling in spontaneously hypertensive rats (SHR) with streptozotocin-induced diabetes.
Methods
Rats were divided into 3 groups: SHR without DM, SHR with DM treated with vehicle and SHR-DM treated with vildagliptin (3mg/kg/day; intragastric gavage). For each group, blood pressure, blood glucose level and body weight were measured serially. Cardiac function was also evaluated by echocardiography. Then, we examined AF inducibility by intracardiac electrophysiological study and the inflammation-induced atrial remodeling by biochemical analysis after 4 weeks of treatment.
Results
There was no significant difference in blood pressure and blood gucose level between vehicle and vildagliptin groups. Administration of vildagliptin significantly reduced AF inducibility compared with rats with vehicle. In DM rats treated with vehicle, rapid atrial pacing promoted the gene expression of inflammatory and fibrosis-related biomarkers (TNF-α, MCP-1, collagen-1) in atrium. Vildagliptin reduced these gene expression levels. In addition, administration of vildagliptin significantly reduced the interstitial fibrosis in atrium.
Conclusions
DPP-4 inhibitor, vildagliptin. could prevent atrial inflammation and reduce the AF inducibility in SHR complicated with DM.
Collapse
Affiliation(s)
- T Soeki
- Tokushima University, Tokushima, Japan
| | | | - D Fukuda
- Tokushima University, Tokushima, Japan
| | - E Uematsu
- Tokushima University, Tokushima, Japan
| | | | - T Tobiume
- Tokushima University, Tokushima, Japan
| | | | - T Ise
- Tokushima University, Tokushima, Japan
| | | | - S Yagi
- Tokushima University, Tokushima, Japan
| | - H Yamada
- Tokushima University, Tokushima, Japan
| | | | - M Sata
- Tokushima University, Tokushima, Japan
| |
Collapse
|
10
|
Ganbaatar B, Fukuda D, Yagi S, Kusunose K, Yamada H, Soeki T, Sata M. P3111Empagliflozin, a SGLT2 inhibitor, attenuates endothelial dysfunction and atherogenesis by inhibiting inflammatory responses in the vasculature and adipose tissue in diabetic apolipoprotein E-deficient. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0186] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Inflammation and oxidative stress associated with hyperglycemia are major causes of vascular dysfunction and cardiovascular complications in diabetes. Recent studies reported that cardioprotective effects of sodium glucose co-transporter 2 (SGLT2) inhibitors, however underlying mechanisms are still obscure.
Purpose
The aim of this study was to investigate whether empagliflozin attenuates atherogenesis and endothelial dysfunction in diabetic apolipoprotein E-deficient (ApoE−/−) mice and investigated underlying mechanisms.
Methods
ApoE−/− mice were injected with streptozotocin (75 mg/kg) for 3 consecutive days. One week after last injection, a western type diet and administration of empagliflozin (20 mg/kg/day) or vehicle via oral gavage were started. Atherosclerotic plaque area was examined by en face Sudan IV staining. Lipid deposition and inflammatory features of atherosclerotic plaques was examined on lesions in the aortic root by immunohistochemical analysis. Vascular function was assessed by isometric tension recording. mRNA or protein expression level was examined by quantitative RT-PCR (qPCR) or western blot analysis, respectively. In in vitro experiments, murine macrophage cell line, RAW264.7, was used.
Results
Treatment with empagliflozin for 12 weeks significantly decreased atherosclerotic plaque size in the aortic arch compared with untreated group (p<0.01). Empagliflozin reduced blood glucose (p<0.001) and plasma lipid levels. Results of histological analyses revealed that empagliflozin decreased lipid deposition, macrophage accumulation, and the expression of inflammatory molecules in the aortic root. Empagliflozin treatment for 8 weeks significantly attenuated endothelial dysfunction as determined by vascular response to acetylcholine. qPCR results demonstrated that empagliflozin reduced the expression of inflammatory molecules such as MCP-1 (p<0.05), ICAM-1 (p<0.05) and Nox-2 (p<0.05), a major NADPH oxidase subunit, in the aorta compared with the untreated group. Furthermore, empagliflozin significantly mitigated the expression of these inflammatory molecules in fat tissues around the aortic arch as determined by qPCR. In in vitro studies, methylglyoxal (MGO), a precursor of AGEs, increased the expression of inflammatory molecules (e.g., MCP-1, IL-1b and TNF-a (p<0.05, respectively)) in RAW264.7 cells. MGO also significantly induced activation of JNK and p38 MAP kinase (p<0.001, respectively) in this cell-type.
Conclusions
Empagliflozin attenuated endothelial dysfunction and atherogenesis in diabetic ApoE−/− mice. Reduction of inflammation in the vasculature and peri-vascular adipose tissues may have a role as underlying mechanisms at least partially.
Collapse
Affiliation(s)
- B Ganbaatar
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - D Fukuda
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardio-Diabetes Medicine, Tokushima, Japan
| | - S Yagi
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - K Kusunose
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - H Yamada
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - T Soeki
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - M Sata
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| |
Collapse
|
11
|
Honda S, Ikeda K, Hoshino A, Urata R, Yagi S, Emoto N, Matoba S. 3306Endothelial cell senescence accelerates atherosclerosis by enhancing monocyte recruitment via hyper-reactivity to inflammatory stimuli. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Ageing is a significant risk factor for atherosclerotic diseases. Vascular senescence has been considered to play an important role in the progression of atherosclerosis; however, it remains unclear whether endothelial cell (EC) senescence is causally involved in the pathogenesis of atherosclerosis.
Purpose
The purpose of this study is to elucidate a causative role of senescent EC in the progression of atherosclerosis.
Methods
Telomeric repeat-binding factor 2 (TRF2) plays a central role in telomere maintenance and protection against end-to-end fusion of chromosome. We previously reported that overexpression of TRF2-dominant negative mutant (TRF2DN) induced premature senescence in EC. We recently generated EC-specific progeroid mice by overexpressing TRF2DN specifically in EC (TRF2DN-Tg), and then generated ApoE-KO/TRF2DN-Tg mice to analyze a role of EC senescence in atherosclerosis. These mice were fed with a high cholesterol-diet, and atherosclerosis was assessed by en face analysis of whole aorta and histological analysis of aortic sinus. In vitro studies to analyze the underlying mechanisms were performed using replicative senescent HUVECs.
Results
En face analysis of aorta revealed that atherosclerotic lesions were significantly increased in ApoE-KO/TRF2DN-Tg mice comparing with that in ApoE-KO mice at as early as 2 weeks after high-cholesterol diet. Histological analysis of aortic sinus also exhibited accelerated atherosclerosis in ApoE-KO/TRF2DN-Tg mice in association with increased macrophage infiltration. Mechanistically, we found that the induction of adhesion molecules such as VCAM-1, ICAM-1, and E-selectin in response to low-grade inflammatory stimuli was substantially augmented in senescent ECs comparing with that in young ECs. As a result, monocyte adhesion was significantly enhanced in senescent ECs. Of note, eNOS inhibition did not affect the hyper-reactivity of senescent EC to inflammation, while antagonizing NF-kB abolished it. Nuclear translocation of NF-kB in response to inflammation was not different between young and senescent ECs, suggesting that NF-kB transcriptional activity might be enhanced in senescent ECs.
Conclusion
We revealed a causative role of EC senescence in the progression of atherosclerosis in vivo using unique EC-specific progeroid mice. Our findings revealed that EC senescence is a bona fide risk for atherosclerosis, and thus senescent ECs are attracting pharmacotherapeutic targets for the prevention and/or treatment of atherosclerotic disease in elderly population.
Collapse
Affiliation(s)
- S Honda
- Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - K Ikeda
- Kobe Pharmaceutical University, Laboratory of Clinical Pharmaceutical Science, Kobe, Japan
| | - A Hoshino
- Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - R Urata
- Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - S Yagi
- Kyoto Prefectural University of Medicine, Kyoto, Japan
| | - N Emoto
- Kobe Pharmaceutical University, Laboratory of Clinical Pharmaceutical Science, Kobe, Japan
| | - S Matoba
- Kyoto Prefectural University of Medicine, Kyoto, Japan
| |
Collapse
|
12
|
Maimaituxun G, Fukuda D, Yagi S, Takao S, Yamada H, Soeki T, Wakatsuki T, Harada M, Sata M, Shimabukuro M. P5304Adipose tissue surrounding the kidney and its impact on coronary artery disease. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.0275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Growing evidence suggests that visceral adipose tissue has systemic and local impact for the development of cardiovascular disease. Previously, we reported that epicardial adipose tissue, as one of visceral fat, was a risk factor for the development of coronary artery disease (CAD). However, the association between another visceral adiposity kidney fat and CAD remains unclear.
Purpose
In this study we aimed to clarify whether there exists link between adipose tissue surrounding the kidney and CAD among patients.
Method
The study population consisted of 201 consecutive patients who underwent 320-slice multi-detector computed tomography (MDCT) coronary angiography. Study subjects were divided into the CAD (≥1 coronary artery stenosis of ≥50%) and non-CAD groups. Adipose tissue surrounding the kidney were quantified by the computed tomography and peri-renal fat volumetric measurements were performed on axial views by manually placing the Region of Interest (ROI) on the renal fascia. The peri-renal fat area of each slice was summed and multiplied by the slice thickness and number of slices to determine the total peri-renal fat volume. Adipose tissue was determined as the density range was −190 to −30 Hounsfield unit. Peri-renal fat volume were indexed by body surface area (BSA).
Results
The mean age was higher in CAD group than those in non-CAD (66±11 vs. 71±10 years, p=0.005). The diabetes, hypertension and hyperlipidemia were significantly prevalent in CAD comparing to non-CAD group. BSA adjusted Peri-renal fat volume was significantly larger in CAD than those in non-CAD (43±27 vs. 60±39 ml/m2). Linear regression analysis showed that BSA adjusted peri-renal fat volume was significantly correlated with visceral fat area (VFA) (R=0.729, p<0.001). Multiple regression analysis for estimating CAD showed that BSA adjusted peri-renal fat volume was a predictor of CAD after adjusting for confounding factors which including age, gender, body mass index, smoking, hypertension, hyperlipidemia, diabetes and VFA (Adjusted R2=0.201, p<0.001); In addition, in the above traditional risk factors model even when the VFA was replaced by the eGFR<60 ml/min/1.73m2, the BSA adjusted peri-renal fat volume still keep a significance for predicting the CAD in the multivariate analysis (Adjusted R2=0.198, p<0.001).
Conclusion
Peri-renal fat volume might be a predictor of CAD. Kidney fat at least partially may contributes to the development of CAD by impaired kidney function.
Collapse
Affiliation(s)
- G Maimaituxun
- Fukushima Medical University, Department of Diabetes, Endocrinology and Metabolism, School of Medicine, Fukushima, Japan
| | - D.A.I.J.U Fukuda
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - S Yagi
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - S Takao
- Institute of Biomedical Sciences,Tokushima University Graduate School, Department of Diagnostic Radiology, Tokushima, Japan
| | - H Yamada
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Soeki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Wakatsuki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Harada
- Institute of Biomedical Sciences,Tokushima University Graduate School, Department of Diagnostic Radiology, Tokushima, Japan
| | - M Sata
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Shimabukuro
- Fukushima Medical University, Department of Diabetes, Endocrinology and Metabolism, School of Medicine, Fukushima, Japan
| |
Collapse
|
13
|
Rahadian A, Fukuda D, Salim H, Yagi S, Kusunose K, Yamada H, Soeki T, Sata M. P722Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0327] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Canagliflozin is a SGLT-2 inhibitor, a novel type of drug for type 2 diabetes mellitus treatment. Recent studies have shown that SGLT-2 inhibitors reduce cardiovascular events, although the mechanism is still unknown.
Purpose
The aim of our study was to examine the effect of canagliflozin on vascular endothelial cell.
Method
Eight-week-old apolipoprotein E-deficient (ApoE−/−) mice were treated with streptozotocin (STZ, 75 mg/kg/day) in three consecutive days by intraperitoneal injection to induce diabetes. Diabetic ApoE−/− mice were treated with canagliflozin (30 mg/kg/day) by gavage for 12 weeks or 8 weeks to examine its effect on atherosclerosis or endothelial function, respectively.
Results
Canagliflozin significantly decreased blood glucose level (P<0.001), triglyceride level (P<0.05), and total cholesterol level (P<0.05). Sudan IV staining on the aortic arch showed that canagliflozin decreased atherosclerotic lesion progression (P<0.05). Histological analyses using atherosclerotic lesions in the aortic root showed that canagliflozin reduced lipid disposition (P<0.01), macrophage accumulation (P<0.001, and expression of adhesion molecules such as ICAM-1, and VCAM-1 (P<0.01, and P<0.05 respectively). Canagliflozin also attenuated the development of endothelial dysfunction as determined by acetylcholine-dependent vasodilation (P<0.05), and reduced the expression of inflammatory molecules, such as ICAM-1 and VCAM-1 (P<0.01), also MCP-1, F4/80, IL6, and iNOS (P<0.05) in the aorta. Canagliflozin reduced oxidative stress as determined by the reduction of the expression of NOX2, NOX4, p22phox, p47phox in the aorta and by the urinary excretion of 8-OHdG. In in vitro experiment using human umbilical vein endothelial cells (HUVEC), methylglyoxal (MGO), a precursor of advanced glycation end products, significantly increased the expression of inflammatory molecules such as ICAM-1, MCP-1, and p22phox in (P<0.05, respectively). MGO also decreased the phosphorylation of eNOSser1177 and Akt, and increased phosphorylation of P38 MAPK in HUVEC.
Conclusion
Glucose lowering effect by canagliflozin attenuates the development of endothelial dysfunction and atherogenesis in diabetic ApoE−/− mice. Anti-inflammatory effect due to the reduction of glucose toxicity on endothelial cells might be one of the mechanisms.
Collapse
Affiliation(s)
- A Rahadian
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - D Fukuda
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardio-Diabetes Medicine, Tokushima, Japan
| | - H Salim
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - S Yagi
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - K Kusunose
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - H Yamada
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Soeki
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| | - M Sata
- Institute of Biomedical Science, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima, Japan
| |
Collapse
|
14
|
Iwamura S, Kaido T, Miyachi Y, Yao S, Shirai H, Kamo N, Yagi S, Uemoto S. OR11: The Impact of Pretransplant Sarcopenia and Perioperative Rehabilitation with Nutritional Therapy on Outcomes After Living Donor Liver Transplantation: A Prospective Study. Clin Nutr 2019. [DOI: 10.1016/s0261-5614(19)32483-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
15
|
Aliyev V, Yagi S, Hammad A, Badawy A, Taura K, Okajima H, Takaori K, Kaido T, Uemoto S. Henoch-Schönlein Purpura After Living Donor Liver Transplantation: Report of the First Case. Transplant Proc 2018; 50:4050-4052. [PMID: 30522857 DOI: 10.1016/j.transproceed.2018.02.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2017] [Revised: 02/22/2018] [Accepted: 02/26/2018] [Indexed: 10/17/2022]
Abstract
Henoch-Schönlein purpura (HSP) is a systemic vasculitis affecting the small vessels that mainly presents in children and young adults. It is characterized by tissue deposition of immunoglobulin A (IgA) immune complexes with the classic manifestations of purpura, arthritis, arthralgia, and gastrointestinal and renal involvements. We report a case of HSP nephritis that occurred 2 years after living-donor liver transplantation (LDLT). After pulse steroid administration, the patient's symptoms disappeared and blood markers normalized. To the best of our knowledge, this is the first HSP case to be reported in a liver transplant recipient.
Collapse
Affiliation(s)
- V Aliyev
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
| | - S Yagi
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
| | - A Hammad
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Surgery, Mansoura University, Mansoura, Egypt
| | - A Badawy
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Surgery, Mansoura University, Mansoura, Egypt; Department of Surgery, Alexandria University, Alexandria, Egypt
| | - K Taura
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - H Okajima
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - K Takaori
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - T Kaido
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - S Uemoto
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| |
Collapse
|
16
|
Soeki T, Uematsu E, Matsuura T, Tobiume T, Kusunose K, Ise T, Yamaguchi K, Yagi S, Fukuda D, Yamada H, Wakatsuki T, Sata M. P3732C-type natriuretic peptide improves left ventricular diastolic dysfunction and ischemia/reperfusion injury-associated ventricular arrhythmias. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- T Soeki
- University of Tokushima, Tokushima, Japan
| | - E Uematsu
- University of Tokushima, Tokushima, Japan
| | - T Matsuura
- University of Tokushima, Tokushima, Japan
| | - T Tobiume
- University of Tokushima, Tokushima, Japan
| | - K Kusunose
- University of Tokushima, Tokushima, Japan
| | - T Ise
- University of Tokushima, Tokushima, Japan
| | | | - S Yagi
- University of Tokushima, Tokushima, Japan
| | - D Fukuda
- University of Tokushima, Tokushima, Japan
| | - H Yamada
- University of Tokushima, Tokushima, Japan
| | | | - M Sata
- University of Tokushima, Tokushima, Japan
| |
Collapse
|
17
|
Maimaituxun G, Shimabukuro M, Fukuda D, Yagi S, Hirata Y, Iwase T, Matsuura T, Ise T, Kusunose K, Tobiume T, Yamaguchi K, Yamada H, Soeki T, Wakatsuki T, Sata M. 106Gender disparities of distribution of epicardial adipose tissue and its impact on coronary artery disease. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy564.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- G Maimaituxun
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Shimabukuro
- Fukushima Medical University, Department of Diabetes, Endocrinology and Metabolism, School of Medicine, Fukushima, Japan
| | - D Fukuda
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - S Yagi
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - Y Hirata
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Iwase
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Matsuura
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Ise
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - K Kusunose
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Tobiume
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - K Yamaguchi
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - H Yamada
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Soeki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - T Wakatsuki
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| | - M Sata
- Institute of Biomedical Sciences, Tokushima University Graduate School, Department of Cardiovascular Medicine, Tokushima City, Japan
| |
Collapse
|
18
|
Ganbaatar B, Fukuda D, Yagi S, Soeki T, Sata M. P6567Inhibition of S1P2 receptor ameliorates endothelial dysfunction and prevents atherogenesis in apolipoprotein-E-deficient Mice. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- B Ganbaatar
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - D Fukuda
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardio-Diabetes Medicine, Tokushima, Japan
| | - S Yagi
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - T Soeki
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - M Sata
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| |
Collapse
|
19
|
Ganbaatar B, Fukuda D, Salim HM, Yagi S, Soeki T, Sata M. P3784Atheroprotective effects of ticagrelor, a P2Y12 antagonist, in apolipoprotein-E-deficient mice. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- B Ganbaatar
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - D Fukuda
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardio-Diabetes Medicine, Tokushima, Japan
| | - H M Salim
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - S Yagi
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - T Soeki
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| | - M Sata
- Institute of Health Biosciences, The University of Tokushima Graduate School, Cardiovascular Medicine, Tokushima, Japan
| |
Collapse
|
20
|
Ito H, Wakatsuki T, Yamaguchi K, Fukuda D, Kawabata Y, Todoroki T, Matsuura T, Ise T, Kusunose K, Tobiume T, Yagi S, Yamada H, Soeki T, Sata M. P2768Growth of vasa vasorum is associated with local inflammation around coronary plaque in fresh cadavers. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2768] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- H Ito
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Wakatsuki
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - K Yamaguchi
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - D Fukuda
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - Y Kawabata
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Todoroki
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Matsuura
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Ise
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - K Kusunose
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Tobiume
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - S Yagi
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - H Yamada
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - T Soeki
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| | - M Sata
- Tokushima University Hospital, Department of Cardiovascular Medicine, Tokushima, Japan
| |
Collapse
|
21
|
Yagi S, Oguri T, Kato H, Yuasa H. Inter-muscle difference in resting compound muscle action potential amplitude and post-exercise facilitation in patients with Lambert-Eaton Myasthenic syndrome: Implications from two cases. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
22
|
Kamo N, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yagi S, Okajima H, Tamai Y, Uemoto S. OR35: Impact of Early Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Outcomes After Liver Transplantation. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30752-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
23
|
Shirai H, Kaido T, Okumura S, Yao S, Kobayashi A, Hamaguchi Y, Yagi S, Kamo N, Okajima H, Uemoto S. SUN-P270: Impact of Sarcopenia on Preoperative Pulmonary Function in Hepato-Billiary Pancreatic Cancer. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30360-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
24
|
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, Kamo N, Yagi S, Taura K, Okajima H, Uemoto S. SUN-P062: Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30565-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Aliyev V, Yasuchika K, Hammad A, Badawy A, Nigmet Y, Tajima T, Fukumitsu K, Yagi S, Hata K, Okajima H, Uemoto S. Coexistent End-stage Nonalcoholic Steatohepatitis and Colon Cancer: Should We Do Liver Transplantation? Transplant Proc 2017; 49:1649-1651. [PMID: 28838457 DOI: 10.1016/j.transproceed.2017.06.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2017] [Accepted: 06/16/2017] [Indexed: 11/28/2022]
Abstract
BACKGROUND Colon cancer accompanying decompensated liver cirrhosis is a rare clinical condition. Usually, treatment of colon cancer is prioritized, with cirrhosis dealt with later. CASE REPORT We present a case of end-stage liver disease due to nonalcoholic steatohepatitis evaluated for living donor liver transplant. During the pretransplant examination, an ascending colon cancer was detected. Liver function was too poor to perform colon resection first. Simultaneous living donor liver transplant and colonic resection were carried out. The patient developed left lung metastasis at 2 different times during the first postoperative year, and both of them were resected. The patient received the standard chemoradiotherapy. Now, the patient is alive at 42 months postprocedure and recurrence-free at 31 months postoperatively. CONCLUSION Simultaneous liver transplantation and colon resection are possible with acceptable long-term outcomes. Immunosuppressive therapy after transplantation increases the risk for cancer recurrence. So the patient should undergo close surveillance.
Collapse
Affiliation(s)
- V Aliyev
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
| | - K Yasuchika
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - A Hammad
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Surgery, Mansoura University, Mansoura, Egypt
| | - A Badawy
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; Department of Surgery, Alexandria University, Alexandria, Egypt
| | - Y Nigmet
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - T Tajima
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - K Fukumitsu
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - S Yagi
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - K Hata
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| | - H Okajima
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
| | - S Uemoto
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
| |
Collapse
|
26
|
Koh Y, Yagi S, Akamatsu H, Tanaka A, Kanai K, Hayata A, Tokudome N, Akamatsu K, Higuchi M, Kanbara H, Ueda H, Nakanishi M, Yamamoto N. Comparison of PD-L1 expression between tumor tissues and circulating tumor cells in patients with lung cancer. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32629-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
27
|
Goigoux T, Ascher P, Blank B, Gerbaux M, Giovinazzo J, Grévy S, Kurtukian Nieto T, Magron C, Doornenbal P, Kiss GG, Nishimura S, Söderström PA, Phong VH, Wu J, Ahn DS, Fukuda N, Inabe N, Kubo T, Kubono S, Sakurai H, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Agramunt J, Algora A, Guadilla V, Montaner-Piza A, Morales AI, Orrigo SEA, Rubio B, Fujita Y, Tanaka M, Gelletly W, Aguilera P, Molina F, Diel F, Lubos D, de Angelis G, Napoli D, Borcea C, Boso A, Cakirli RB, Ganioglu E, Chiba J, Nishimura D, Oikawa H, Takei Y, Yagi S, Wimmer K, de France G, Go S, Brown BA. Two-Proton Radioactivity of ^{67}Kr. Phys Rev Lett 2016; 117:162501. [PMID: 27792367 DOI: 10.1103/physrevlett.117.162501] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Indexed: 06/06/2023]
Abstract
In an experiment with the BigRIPS separator at the RIKEN Nishina Center, we observed two-proton (2p) emission from ^{67}Kr. At the same time, no evidence for 2p emission of ^{59}Ge and ^{63}Se, two other potential candidates for this exotic radioactivity, could be observed. This observation is in line with Q value predictions which pointed to ^{67}Kr as being the best new candidate among the three for two-proton radioactivity. ^{67}Kr is only the fourth 2p ground-state emitter to be observed with a half-life of the order of a few milliseconds. The decay energy was determined to be 1690(17) keV, the 2p emission branching ratio is 37(14)%, and the half-life of ^{67}Kr is 7.4(30) ms.
Collapse
Affiliation(s)
- T Goigoux
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - P Ascher
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - B Blank
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - M Gerbaux
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - J Giovinazzo
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - S Grévy
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - T Kurtukian Nieto
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - C Magron
- Centre d'Études Nucléaires de Bordeaux Gradignan, Université de Bordeaux-UMR 5797 CNRS/IN2P3, Chemin du Solarium, 33175 Gradignan, France
| | - P Doornenbal
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - G G Kiss
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Nishimura
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - P-A Söderström
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - V H Phong
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - J Wu
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - D S Ahn
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - N Fukuda
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - N Inabe
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - T Kubo
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - S Kubono
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - H Sakurai
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Physics, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - Y Shimizu
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - T Sumikama
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - H Suzuki
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - H Takeda
- RIKEN Nishina Center, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - J Agramunt
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - A Algora
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
- Institute of Nuclear Research of the Hungarian Academy of Sciences, P.O. Box 51, H-4001 Debrecen, Hungary
| | - V Guadilla
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - A Montaner-Piza
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - A I Morales
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - S E A Orrigo
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - B Rubio
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
| | - Y Fujita
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
- Research Center for Nuclear Physics, Osaka University, Ibaraki, Osaka 567-0047, Japan
| | - M Tanaka
- Department of Physics, Osaka University, Toyonaka, Osaka 560-0043, Japan
| | - W Gelletly
- Instituto de Física Corpuscular, CSIC-Universidad de Valencia, E-46071 Valencia, Spain
- Department of Physics, University of Surrey, Guildford GU2 7XH, United Kingdom
| | - P Aguilera
- Comisión Chilena de Energía Nuclear, Casilla 188-D, Amunátegui 95, Santiago Centro, Santiago, Chile
| | - F Molina
- Comisión Chilena de Energía Nuclear, Casilla 188-D, Amunátegui 95, Santiago Centro, Santiago, Chile
| | - F Diel
- Institute of Nuclear Physics, University of Cologne, D-50937 Cologne, Germany
| | - D Lubos
- Physik Department E12, Technische Universität München, D-85748 Garching, Germany
| | - G de Angelis
- Laboratori Nazionali di Legnaro dell'INFN, I-35020 Legnaro (Padova), Italy
| | - D Napoli
- Laboratori Nazionali di Legnaro dell'INFN, I-35020 Legnaro (Padova), Italy
| | - C Borcea
- National Institute for Physics and Nuclear Engineering IFIN-HH, P.O. Box MG-6, Bucharest-Magurele, Romania
| | - A Boso
- INFN Sezione di Padova and Dipartimento di Fisica, Università di Padova, I-35131 Padova, Italy
| | - R B Cakirli
- Department of Physics, Istanbul University, Istanbul 34134, Turkey
| | - E Ganioglu
- Department of Physics, Istanbul University, Istanbul 34134, Turkey
| | - J Chiba
- Department of Physics, Tokyo University of Science, Noda, Chiba 278-8510, Japan
| | - D Nishimura
- Department of Physics, Tokyo University of Science, Noda, Chiba 278-8510, Japan
| | - H Oikawa
- Department of Physics, Tokyo University of Science, Noda, Chiba 278-8510, Japan
| | - Y Takei
- Department of Physics, Tokyo University of Science, Noda, Chiba 278-8510, Japan
| | - S Yagi
- Department of Physics, Tokyo University of Science, Noda, Chiba 278-8510, Japan
| | - K Wimmer
- Department of Physics, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
| | - G de France
- Grand Accélérateur National d'Ions Lourds, B.P. 55027, F-14076 Caen Cedex 05, France
| | - S Go
- Department of Physics and Astronomy, University of Tennessee, 401 Nielsen Physics Building, 1408 Circle Drive, Knoxville, Tennessee 37996-1200, USA
| | - B A Brown
- Department of Physics and Astronomy, and National Superconducting Cyclotron Laboratory, Michigan State University, East Lansing, Michigan 48824-1321, USA
| |
Collapse
|
28
|
Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yagi S, Taura K, Okajima H, Uemoto S. SUN-P049: The Impact of Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection of Colorectal Liver Metastases. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30392-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
29
|
Okumura S, Kaido T, Hamaguchi Y, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S. MON-P060: Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma. Clin Nutr 2016. [DOI: 10.1016/s0261-5614(16)30694-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
30
|
Kaido T, Tamai Y, Hamaguchi Y, Okumura S, Kobayashi A, Yagi S, Okajima H, Inagaki N, Uemoto S. MON-PP066: Impact of Pretransplant Sarcopenia and Sequential Changes in Sarcopenic Parameters after Living Donor Liver Transplantation: A Prospective Study. Clin Nutr 2015. [DOI: 10.1016/s0261-5614(15)30498-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
31
|
Tsukada C, Tsuji T, Matsuo K, Nomoto T, Kutluk G, Sawada M, Ogawa S, Yoshida T, Yagi S. Spectroscopic and morphological studies on interaction between gold nanoparticle and liposome constructed with phosphatidylcholine. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/1757-899x/76/1/012001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
|
32
|
Yagi S, Menjo Y, Tsukada C, Ogawa S, Kutluk G, Namatame H, Taniguchi M. Vulcanization reaction of squalene and S8powder studied by Sulfur K-edge NEXAFS under liquid phase. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/1757-899x/76/1/012004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
33
|
Yagi S, Shirai M, Kanzaki M, Nakayama M, Utsunomiya T, Sugimoto K, Ohtani H, Harada M. 424. Laparoscopy endoscopy cooperation partial gastrectomy. Eur J Surg Oncol 2014. [DOI: 10.1016/j.ejso.2014.08.414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
34
|
Iida T, Kaido T, Yagi S, Hori T, Uchida Y, Jobara K, Tanaka H, Sakamoto S, Kasahara M, Ogawa K, Ogura Y, Mori A, Uemoto S. Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases. Clin Transplant 2014; 28:1025-30. [DOI: 10.1111/ctr.12412] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2014] [Indexed: 02/01/2023]
Affiliation(s)
- T. Iida
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - T. Kaido
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - S. Yagi
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - T. Hori
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - Y. Uchida
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - K. Jobara
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - H. Tanaka
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - S. Sakamoto
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - M. Kasahara
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - K. Ogawa
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - Y. Ogura
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - A. Mori
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| | - S. Uemoto
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery; Department of Surgery; Graduate School of Medicine; Kyoto University; Kyoto Japan
| |
Collapse
|
35
|
Tsukada C, Tsuji T, Matsuo K, Nameki H, Yoshida T, Yagi S. Study on interaction between phosphatidylcholine(PC) liposome and gold nanoparticles by TEM observation. ACTA ACUST UNITED AC 2014. [DOI: 10.1384/jsa.20.230] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Affiliation(s)
- C. Tsukada
- Department of Quantum Engineering, Graduate School of Engineering, Nagoya University
| | - T. Tsuji
- Department of Materials Science and Engineering, Graduate School of Engineering, Nagoya University
| | - K. Matsuo
- Synchrotron Radiation Center, Hiroshima University
| | - H. Nameki
- Aichi Center for Industry and Science Technology
| | - T. Yoshida
- EcoTopia Science Institute, Nagoya University
| | - S. Yagi
- Synchrotron Radiation Center, Hiroshima University
- EcoTopia Science Institute, Nagoya University
| |
Collapse
|
36
|
Bando S, Soeki T, Matsuura T, Yagi S, Fukuda D, Hirotsugu Y, Wakatsuki T, Shimabukuro M, Kangawa K, Sata M. Plasma Brain Natriuretic Peptide (BNP) level is elevated in patients with cancer. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht310.4572] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
37
|
Ishida M, Shimabukuro M, Yagi S, Fukuda D, Soeki T, Sato H, Uematsu E, Izaki H, Kanayama H, Sata M. MicroRNA-100 regulates a cluster of adipocytokine expression: A human biopsy study in subcutaneous and visceral adipose tissue. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3265] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
38
|
Nishikawa K, Yagi S, Ise T, Ueda Y, Iwase I, Akaike M, Shimabukuro M, Kato S, Sata M. Visceral fat mass is associated with daily physical activity, leg skeletal muscle mass and fiber intake in healthy men. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Yamaguchi K, Wakatsuki T, Niki T, Taketani Y, Ise T, Yagi S, Iwase T, Yamada H, Soeki T, Sata M. Differential responses of local coagulation after implantation of everolimus-eluting and zotarolimus-eluting stents compared with early-generation drug-eluting stents in patients with stable angina. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
40
|
Ishida M, Shimabukuro M, Yagi S, Fukuda D, Soeki T, Sato H, Uematsu E, Izaki H, Kanayama H, Sata M. MicroRNA miR-378 regulates adipocytokine fate by targeting transcriptional factors in human visceral and subctaneous adipose tissue. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3262] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
41
|
Nishimoto S, Fukuda D, Shimabukuro M, Matsumoto S, Ishida M, Yagi S, Soeki T, Sakaue H, Nakaya Y, Sata M. Genetic ablation of TLR9 improves insulin resistance through macrophage accumulation in adipose tissue. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p3267] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
42
|
Iwase T, Takao T, Akaike M, Ise T, Yagi S, Yamaguchi K, Yamada H, Nishioka Y, Harada M, Sata M. Differentiation of left ventricular systolic dysfunction related to cardiac sarcoidosis and other heart diseases using contrast-enhanced cardiovascular magnetic resonance. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p4215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
43
|
Kaido T, Ogawa K, Fujimoto Y, Ogura Y, Hata K, Ito T, Tomiyama K, Yagi S, Mori A, Uemoto S. Impact of sarcopenia on survival in patients undergoing living donor liver transplantation. Am J Transplant 2013; 13:1549-56. [PMID: 23601159 DOI: 10.1111/ajt.12221] [Citation(s) in RCA: 270] [Impact Index Per Article: 24.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Revised: 02/07/2013] [Accepted: 02/09/2013] [Indexed: 02/06/2023]
Abstract
Skeletal muscle depletion, referred to as sarcopenia, predicts morbidity and mortality in patients undergoing digestive surgery. However, the impact on liver transplantation is unclear. The present study investigated the impact of sarcopenia on patients undergoing living donor liver transplantation (LDLT). Sarcopenia was assessed by a body composition analyzer in 124 adult patients undergoing LDLT between February 2008 and April 2012. The correlation of sarcopenia with other patient factors and the impact of sarcopenia on survival after LDLT were analyzed. The median ratio of preoperative skeletal muscle mass was 92% (range, 67-130%) of the standard mass. Preoperative skeletal muscle mass was significantly correlated with the branched-chain amino acids to tyrosine ratio (r = -0.254, p = 0.005) and body cell mass (r = 0.636, p < 0.001). The overall survival rate in patients with low skeletal muscle mass was significantly lower than in patients with normal/high skeletal muscle mass (p < 0.001). Perioperative nutritional therapy significantly increased overall survival in patients with low skeletal muscle mass (p = 0.009). Multivariate analysis showed that low skeletal muscle mass was an independent risk factor for death after transplantation. In conclusion, sarcopenia was closely involved with posttransplant mortality in patients undergoing LDLT. Perioperative nutritional therapy significantly improved overall survival in patients with sarcopenia.
Collapse
Affiliation(s)
- T Kaido
- Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
|
45
|
Yagi S, Nagai K, Kadaba P, Afify M, Teramukai S, Uemoto S, Tolba RH. A novel organ preservation for small partial liver transplantations in rats: venous systemic oxygen persufflation with nitric oxide gas. Am J Transplant 2013; 13:222-8. [PMID: 23126657 DOI: 10.1111/j.1600-6143.2012.04310.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2012] [Revised: 08/21/2012] [Accepted: 08/30/2012] [Indexed: 01/25/2023]
Abstract
The prognosis for recipients of small liver grafts is poor. The aim of this study was to determine the impact of venous systemic oxygen persufflation (VSOP) with nitric oxide (NO) gas for 30% partial liver preservation and transplantation in rats. After we determined optimal NO concentration as 40 ppm in vitro with the isolated perfused rat liver model, we assessed liver injury and regeneration in vivo at 1, 3, 24 and 168 h after transplantation in the following three groups after 3 h-cold storage (n = 20 per group): control group = static storage; VSOP group = oxygen persufflation and VSOP+NO group = oxygen with NO persufflation. The liver graft persufflation was achieved with medical gas via the suprahepatic vena cava; In comparison with control group after transplantation, VSOP+NO preservation (1) increased portal circulation, (2) reduced AST and ALT release, (3) upregulated hepatic endothelial NO synthase, (4) reduced hepatocyte and bileductule damage and (5) improved liver regeneration. These results suggest that gaseous oxygen with NO persufflation is a novel and safe preservation method for small partial liver grafts, not only alleviating graft injury but also improve liver regeneration after transplantation.
Collapse
Affiliation(s)
- S Yagi
- Institute for Laboratory Animal Science and Experimental Surgery, RWTH-Aachen University, Germany
| | | | | | | | | | | | | |
Collapse
|
46
|
Shehata MR, Yagi S, Okamura Y, Iida T, Hori T, Yoshizawa A, Hata K, Fujimoto Y, Ogawa K, Okamoto S, Ogura Y, Mori A, Teramukai S, Kaido T, Uemoto S. Pediatric liver transplantation using reduced and hyper-reduced left lateral segment grafts: a 10-year single-center experience. Am J Transplant 2012; 12:3406-13. [PMID: 22994696 DOI: 10.1111/j.1600-6143.2012.04268.x] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Few studies have examined the long-term outcomes and prognostic factors associated with pediatric living living-donor liver transplantation (LDLT) using reduced and hyper-reduced left lateral segment grafts. We conducted a retrospective, single-center assessment of the outcomes of this procedure, as well as clinical factors that influenced graft and patient survival. Between September 2000 and December 2009, 49 patients (median age: 7 months, weight: 5.45 kg) underwent LDLT using reduced (partial left lateral segment; n = 5, monosegment; n = 26), or hyper-reduced (reduced monosegment grafts; n = 18) left lateral segment grafts. In all cases, the estimated graft-to-recipient body weight ratio of the left lateral segment was more than 4%, as assessed by preoperative computed tomography volumetry, and therefore further reduction was required. A hepatic artery thrombosis occurred in two patients (4.1%). Portal venous complications occurred in eight patients (16.3%). The overall patient survival rate at 1, 3 and 10 years after LDLT were 83.7%, 81.4% and 78.9%, respectively. Multivariate analysis revealed that recipient age of less than 2 months and warm ischemic time of more than 40 min affected patient survival. Pediatric LDLT using reduced and hyper-reduced left lateral segment grafts appears to be a feasible option with acceptable graft survival and vascular complication rates.
Collapse
Affiliation(s)
- M R Shehata
- Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University, Kyoto, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Kobayashi A, Tanizaki Y, Yamamoto M, Shiro M, Yagi S, Minami S, Ino K. W139 FIFTEEN CASES OF CHRONIC ABRUPTION-OLIGOHYDRAMNIOS SEQUENCE (CAOS). Int J Gynaecol Obstet 2012. [DOI: 10.1016/s0020-7292(12)61864-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Yagi S, Iida T, Hori T, Taniguchi K, Nagahama M, Isaji S, Uemoto S. Effect of portal haemodynamics on liver graft and intestinal mucosa after small-for-size liver transplantation in swine. ACTA ACUST UNITED AC 2012; 48:163-70. [PMID: 22653087 DOI: 10.1159/000338622] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2011] [Accepted: 04/01/2012] [Indexed: 12/12/2022]
Abstract
BACKGROUND After small-for-size graft (SFSG) transplantation, elevated portal venous pressure (PVP) may lead to postoperative liver damage. Herein we evaluated the impact of portocaval shunt (PCS) to control PVP on liver grafts and intestine following SFSG transplantation. METHODS Nineteen SFSG transplantations were performed with 30% of native liver in swine. Swine were divided into 3 groups: a high-flow shunt group (HS: n = 7), in which portal venous flow (PVF) was reduced with a 10-mm diameter PCS; a low-flow shunt group (LS: n = 6), in which PVF was reduced with a 5-mm diameter PCS, and a no-shunt group (NS: n = 6), in which no PCS was placed. RESULTS Seven-day survivals were 83.3% in NS, 100% in LS and 0% in HS (p = 0.0088). PVP was significantly higher in the NS group (p = 0.0001; mean ± SEM NS/LS/HS: 20.5 ± 0.7/14.0 ± 1.2/11.6 ± 0.5 mm Hg). The LS group exhibited the highest compliance (PVF/PVP; NS/LS/HS 42.7 ± 10.9/44.6 ± 4.9/37.7 ± 8.3 ml/min/mm Hg; p = 0.009), the lowest aspartate aminotransferase (NS/LS/HS 562 ± 18/370 ± 55/720 ± 130 IU/l; p = 0.0493), and suppressed deleterious alternations of the hepatic parenchyma and intestinal mucosa. CONCLUSIONS Portal hypertension after SFSG transplantation impaired liver and intestinal mucosa; however, inadequate portal flow impaired not only the liver, but also survival.
Collapse
Affiliation(s)
- S Yagi
- Department of Hepatobiliary, Pancreas and Transplant Surgery, Kyoto University Graduate School of Medicine, Kyoto City, Japan.
| | | | | | | | | | | | | |
Collapse
|
49
|
Yagi S, Yagi AI, Gadir EHA, Henry M, Chapleur Y, Laurain-Mattar D. Toxicity of Hydnora johannis Becca. dried roots and ethanol extract in rats. J Ethnopharmacol 2011; 137:796-801. [PMID: 21762770 DOI: 10.1016/j.jep.2011.06.044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/01/2011] [Revised: 05/23/2011] [Accepted: 06/28/2011] [Indexed: 05/31/2023]
Abstract
AIM OF THE STUDY Hydnora johannis Becca. (Hydnoraceae) commonly is used for the treatment of dysentery, diarrhoea, cholera and swelling tonsillitis in the folk medicine of Sudan and other African countries. This study evaluates the toxicological effects of Hydnora johannis roots on Wistar rats. MATERIALS AND METHODS Rats were randomized into control, groups fed with 2, 10, 20% of dried roots for 8 weeks and other groups given ethanol extract (50, 100, 200 and 400mg/kg/day) through oral and intramuscularly administration for 2 weeks. Toxicity was evaluated using biochemical and histopathological assays. RESULTS Alterations in the levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, cholesterol and urea were observed. Histopathological analysis revealed that the toxic effect were mainly on the liver, kidney and spleen on all treated groups. However, the impact of the dried roots was mild compared to the ethanol extract. Remarkably, there was a drop in cholesterol level in all treatment groups suggesting the antiartherogenic effect of Hydnora johannis roots. CONCLUSION The results from this study suggest that the powder preparation as well as ethanolic extract of Hydnora johannis roots induced toxic effect on Wistar rats. The observed toxic effect might be due to the dose and/or frequency of administration. Although in traditional medicine the extract is administrated in low dose, the results suggest the necessity of standardization of the drug.
Collapse
Affiliation(s)
- S Yagi
- Groupe S.U.C.R.E.S., UMR 7565 CNRS-Nancy-Université, BP 239,54506 Nancy-Vandoeuvre, France
| | | | | | | | | | | |
Collapse
|
50
|
|